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Abstract
Naturally occurring tumor in animals receiving high minerals from deep oceans 
(DOM: hardness 600  mg/L) from 6  months of age until natural death was firstly 
assessed in 200 Sprague Dawley rats, randomized into four groups: Control (C), 
DOM (D), Fructose (F), and Fructose + DOM (FD). Fructose drink contained 11% 
fructose. Tumor incidence (necropsy at death) in the D group was ~40% lower than 
that in the C group (P < .05), together with lower body mass gain and greater lo-
comotive activity during their initial 18 months (P < .05) but not during later life. 
X-ray image analysis on abnormal solid tissue among survivors at 18 and 24 months 
of age confirms a similar trend, exhibiting ~50% and ~65% lower tumor incidence 
than the C and F groups, respectively. Reduced-to-oxidized glutathione ratio (GSH/
GSSG) declined with age for the first three quarters of life on all groups (P < .05), 
followed by a resurgence during end-life among survivors at 24 months. This resur-
gence is markedly associated with lower tumor expansion but unrelated with DOM 
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1 |  INTRODUCTION
Deep oceans have been proposed as a possible site for the 
origins of life.1 If terrestrial organisms are survived descen-
dants who evolved from deep oceans, supplementation of 
deep ocean components to terrestrial animals should replen-
ish loss of nutritive complexity associated with evolutionary 
sea-to-land migration. Deep oceans contain a great variety of 
minerals and trace elements, supporting a massive amount of 
marine organisms.2 However, ocean surface water is exhausted 
of biogenic nutrients, to some extent, by photosynthesis in the 
light permeable zone (~200 m). This is supported by superior 
health benefits of deep ocean water for terrestrial mammals 
than surface water with a similar major mineral profile.3
Studies in cell culture have suggested an inhibitory effect of 
DOM on the metastatic potential of breast cancer cells4 and col-
orectal adenocarcinomas cells.5 While most of in vivo studies 
are documented using tumor-implanted young mammals, tumor 
incidence is generally known to increase during late life. Tumor 
incidence is partly associated with a lack of minerals6,7 and 
seems to involve with an age-dependent decline in GSH/GSSG 
levels.8,9 However, a longitudinal investigation on GSH/GSSG 
changes over the lifespan, together with tumor incidence, has 
not previously been reported in mammals supplemented with a 
high concentration of minerals and trace elements.
The life-prolonging effect of DOM consumption in mam-
mals has been previously reported under pathogenic condi-
tions.10,11 Approximately 57% of the ovariectomized mice 
survived up to 16.6 months of age with DOM supplementa-
tion, whereas the untreated mice died at around 10 months of 
age.11 For streptozotocin-induced diabetic rats, the survival 
rate was ~3 times higher in rats consuming DOM with mod-
erate improvement in fasting glucose levels compared with 
the control rats.10 Tumor incidence during aging was not re-
ported in both studies.
It is currently unknown whether prolonged consumption 
of desalinated DOM, containing high concentration of min-
erals and trace element, influences tumor incidence, survival 
time and physical vitality of naturally aging terrestrial ani-
mals. Therefore, the current study examines whether tumor 
incidence, longevity, and physical vitality in naturally aging 
rats can be altered by lifelong DOM drinking.
This study hypothesizes that components in DOM are able 
to compensate the loss of molecular complexity for terrestrial 
mammals associated with evolutionary sea to land migration. 
To evaluate this concept, survival time, tumor incidence, and 
physical vitality were measured.
Since fructose is a commonly used sweetener in bever-
ages and is known to promote tumor growth,12 DOM drink 
was delivered in both fructose and fructose-free forms.
2 |  METHODS
2.1 | Animals
A total of 200 Sprague Dawley rats (sex balanced) with known 
date of birth were obtained from LASCO Corporation. Rats 
were transferred to the Animal Center of University of Taipei at 
1 month of age (weighed 111 ± 1 g). Two animals were housed 
per cage and provided standard laboratory chow (LabDiet). 
Cages were kept in an animal room with 12/12 hours light/dark 
cycle, 22 ± 2°C, and 50% relative humidity.
2.2 | Experimental design
To evaluate the effect of DOM on aging-associated tu-
morigenesis, vitality and longevity, the six rats that sur-
vived less than 12 months were excluded from analysis. 
Rats were randomized into the following four groups: 
Control (C, n  =  49), DOM (D, n  =  48), Fructose (F, 
n = 49), Fructose + DOM (FD, n = 48). A DOM drink 
with or without fructose (11% W/V) was provided daily 
from 6 months of age until natural death. Tap water used 
to dissolve fructose and DOM was served as the con-
trol drink. Food and drink were provided ad libitum for 
all animals, with consumption volume recorded every 
3 days. Total energy intake from standard chow was cal-
culated according to nutritional information provided by 
the manufacturers (Normal Chow #5001, LabDiet) and 
where applicable added to the fructose consumption in 
the drink. Body composition, spontaneous locomotive ac-
tivity, fasting glucose, glucose levels during insulin toler-
ance test (ITT), reduced glutathione (GSH) to oxidized 
glutathione (GSSG) ratio, and tumor size progression (X-
ray image) were measured at the age of 6th, 12th, 18th, 
and 24th months.
supplementation. Our results demonstrate valuable application of minerals and trace 
elements from deep oceans, as a vastly available natural source, on tumor suppression 
during normal aging.
K E Y W O R D S
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2.3 | Deep ocean minerals
The DOM used in this study was supplied by Taiwan Yes 
Deep Ocean Water Co., LTD, collected from the depth of 
662 meters below earth's surface in the West Pacific Ocean, 
Hualien, Taiwan. The DOM drink was diluted in tap water 
from a concentrate of desalinated seawater with or without 
fructose (11%) to reach a hardness of 600 mg/L, according 
to a previous study.13 Table 1 shows the mineral and trace 
element profile of the DOM used in this study. Consistency 
of major mineral levels of the DOM in the past 5 years has 
been confirmed for potassium, sodium, magnesium, chlo-
ride, bromide, and calcium content under the same hardness 
(pH 8.1).
2.4 | Blood sample collection
Blood samples were always collected after 12 hours of fast-
ing from tails of rats into an EDTA containing tube. After 
centrifugation of blood samples at 3000 rpm for 10 minutes 
at 4°C, plasma samples were transferred into Eppendorf 
tubes for storage at −80°C until analysis.
2.5 | Reduced and oxidized glutathione
Glutathione fluorometric assay kits (Biovision) were used 
to measure reduced glutathione (GSH) and oxidized glu-
tathione (GSSG) levels. Briefly, 60 μL of plasma samples 
were centrifuged in a tube containing 20 μL ice-cold per-
chloric acid, vortexed, and kept on ice for 5 minutes, then 
spun for 2 minutes at 13 000 g at 4°C and the resultant su-
pernatant collected. The supernatants were then assayed ac-
cording to the manufacturer’s instructions, using an ELISA 
reader (Tecan GENios, A-5082). Glutathione levels were 
expressed as μg/mL.
2.6 | Insulin tolerance test (ITT)
After 12 hours of fasting, anesthetized rats received an intraperi-
toneal insulin injection (0.3 U/kg body mass). Blood glucose lev-
els (mg/dL) were measured immediately using the Accu-chek® 
performa system (Roche Diagnostics) before (0  minutes) and 
30, 60, 90, and 120 minutes after insulin injection. Plasma insu-
lin levels (μg/L) were measured on the same day of blood collec-
tion using an enzyme-linked immunosorbent assay (ELISA) kit 
(Mercodia, Mercodia AB). Optical density values were read at 
450 nm using an ELISA reader (Tecan GENios, A-5082).
2.7 | Dual-energy X-ray absorptiometry 
(DEXA)
Body composition of rats was measured by DEXA (Lunar 
iDXA, GE Medical Systems) and analyzed using a specific 
small animal software package. Body composition was 
determined by image analysis using GE's Lunar software 
enCORE™ (GE Medical Systems). DEXA scans were per-
formed under isofluorane anesthesia following 12 hours of 
fasting. Body composition data including lean mass (g), 
fat mass (g), bone mass (g), bone mineral density (BMD) 
(g/cm2), and % bone mass (% body mass) were recorded.
2.8 | Tumor assessments
Necropsy after natural death was used for tumor assessment 
to generate data on tumor incidence. For necropsy analysis, 
deceased rats had gross autopsies by a certified specialist. To 
assess tumor size expansion, abnormal solid tissues on X-ray 
image from DEXA were measured at 6th, 12th, 18th, and 
24th months. Tumor volume (V) was determined by the larg-
est (a) and smallest (b) superficial visible diameters on x-ray 
images and calculated based on formula [V = a × (b2)/2].14
2.9 | Spontaneous locomotive activity
To assess physical vitality of the animals, spontaneous lo-
comotor activity was monitored using a Locoscan video 
tracking system (Clever Sys, VA, USA) on a black plastic 
cage (40 cm × 40 cm).15 One week prior to assessment, rats 
were familiarized to the plastic cage for 10  min/day with 
spontaneous locomotive activity measured in quiet and dark 
environments. Rats were placed in the center of the plastic 
cage and allowed to move freely. Daily spontaneous loco-
motive activity of rats was recorded for 20 minutes by the 
camera mounted above the center of the testing cage. The 
first and last 5 minute periods were removed from analysis to 
avoid disturbances related to human access to the dark room. 
T A B L E  1  Mineral and trace element profile of the deep ocean-
based mineral water
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Artifact due to feces and urine was removed. Ten-min video 
data were analyzed using the Locoscan software (Clever Sys) 
providing values on horizontal movement distance (cm) and 
movement speed (mm/s).
2.10 | Statistical analysis
Survival curves for different groups were presented 
by Kaplan-Meier curve. One-way analysis of variance 
(ANOVA) was conducted to determine the difference 
among four groups of all variables. Repeated measure anal-
ysis was used to determine the group difference of all varia-
bles within the same survivors at different time points (6th, 
12th, 18th, 24th month) for 24th month. The Duncan post 
hoc test was used to distinguish mean differences between 
pair of groups. A two-way ANOVA was used to analyze the 
treatment effects of the DOM and fructose drinks, and time 
effects over the animal lifespan. The difference in tumor in-
cidence among groups was compared by Chi-squared test. 
All values are expressed as mean ± standard error (SE). A 
level of P <  .05 was set for statistical significance for all 
tests.
3 |  RESULTS
3.1 | Lifespan
Data for longevity and body mass trajectory are shown in 
Figure 1. The average lifespan of each group was ~24 months 
(Figure 1A). No significant difference in average lifespan was 
observed among groups (C: 749 ± 25 days; D: 725 ± 23 days; 
F: 709 ± 25 days; FD; 717 ± 21 days). For body mass trajec-
tory (Figure 1B), only those rats survived at 24 months were 
included to calculate the mean mass (n = 102). Body mass in 
the fructose-fed groups was significantly greater than that in 
the non-fructose-fed groups (P < .05) overtime. Body mass of 
the D group was significantly lower than that of the C group 
during the same period (P < .05). Survivor numbers declined 
rapidly after 24  months of age for all groups (Figure  1B). 
Rapid loss of body mass before death is a common feature 
during end stage of life for all groups (after 24 months of age, 
body mass values are averaged among survivors). Rats in the 
fructose-fed rats had more body mass than those in the fruc-
tose free group among survivors after 24 months of age (main 
treatment effect, P < .05). D group showed lowest body mass 
compared with the rest of other groups during the same period 
(P < .05 vs C group).
3.2 | Food and water consumption
Fructose and DOM interventions started from 6  months 
of age. Food, water, and total energy intake from rats 
survived at 24 months are shown in Figure 2. Food con-
sumption decreased (Figure  2A) and water consumption 
(Figure  2B) increased significantly in the fructose-fed 
groups after 6 months of age. Energy distribution in fruc-
tose-fed groups was ~40% derived from fructose. Food, 
water, and energy intake (Figure 2C) in the DOM groups 
were lower than those in the DOM-free groups after the 
DOM intervention at 6 months of age (main treatment ef-
fect, P < .05).
3.3 | Tumor incidence
Tumor incidence, examined by necropsies at death 
(Figure 3A), of the D group was ~40% less than that of the C 
F I G U R E  1  Longevity and body mass. No significant difference in cumulative survival (A) of the rats (n = 194, average lifespan: ~24 mo) 
survived over 12 mo among 4 groups (C, n = 49; D, n = 48; F, n = 49; FD, n = 48). Trajectory lines represent evolution of mean body mass of 
survivors (n = 102) at 24 mo (B) (C, n = 26; D, n = 28; F, n = 25; FD, n = 23). Significant body mass loss was observed for all groups after 24 mo 
of age. The D group had the lowest body mass from 19 mo of age. *P < .05 compared with C, F, and FD groups. Abbreviation: C, Control; D, 
Deep ocean mineral water; F, Fructose; FD, Fructose + Deep ocean mineral water
A B
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group (P < .05). Tumor size development, based on abnormal 
solid tissue on X-ray image (Figure 3D), was measured every 
6  months until 24  months of age. Tumor incidence in the 
fructose-fed survivors was significantly increased between 
18 and 24 months (Figure 3B; main time effect, P <  .05). 
Tumor size expansion from 18 to 24 months of age showed 
F I G U R E  2  Food and drink consumption. Fructose drinks reduced food consumption by nearly 50% (A) and substantially increased water 
consumption (B) from 6 mo of age. Total energy intake in the DOM-treated groups was moderately lower than those in the non-DOM groups from 
6 to 12 mo of age (P < .05) (C). Trajectory lines represent mean values of each group (n = 102) survived at 24 mo (B) (C, n = 26; D, n = 28; F, 
n = 25; FD, n = 23). Abbreviation: C, Control; D, Deep ocean mineral water; F, Fructose; FD, Fructose + Deep ocean mineral water. The arrow in 
the figure represents the time when the experiment was started
A B C
F I G U R E  3  Tumor incidence and tumor size expansion. Tumor incidence (necropsy) of the rats in the D group was ~40% less than that in 
the C group (A). Representative X-ray tumor image of a rat (D), measured every 6 mo until 24 mo of age. Age-dependent tumor incidence (X-ray 
image) increased dramatically from 18 to 20 mo of age, in which fructose-fed groups showed greater increases in tumor incidence than those non-
fructose-fed groups (B). Tumor size expansion from 18 to 24 mo showed similar trend among four groups but no statistical significance is reached 
(C). Abbreviation: C, Control; D, Deep ocean mineral water; F, Fructose; FD, Fructose + Deep ocean mineral water. *P < .05 compared against the 
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similar trend with aforementioned tumor incidence but statis-
tical significance is not reached (P = .24 vs C group; P = .07 
vs F group; P = .16 vs FD group) (Figure 3C). Tumor loca-
tion and number among four treatment groups are detailed in 
Table 2.
3.4 | Blood glucose and insulin
Trajectories of fasting glucose, fasting insulin, and glucose 
AUC of the rats survived at 24 months are shown in Figure 4. 
Fasting glucose (Figure 4A) and glucose AUC (Figure 4C) in 
the fructose-fed rats were increased at 12 months and gradu-
ally declined thereafter. Plasma insulin levels (Figure 4B) in 
the rats from all groups increased to its peak at 18 months of 
age and declined thereafter by 22% until 24  months of age 
(main time effect, P < .05). Insulin levels in the fructose-fed 
rats were significantly greater than those in the fructose-free 
rats at 12 months of age (main treatment effect, P < .05). No 
significant differences in fasting glucose, insulin, and glucose 
AUC between the DOM-treated and DOM-free groups were 
observed.
3.5 | Body composition
Trajectories of lean mass and fat mass of rats survived at 
24 months are shown in Figure 5. Lean mass increased sig-
nificantly from 6 to 12  months and remained stable until 
24 months of age. No treatment effects of DOM and fructose 
were found on lean mass (Figure 5A). From 6 to 24 months 
of age, fat mass (Figure  5B) from all groups increased 
progressively (main time effect, P  <  .05). Fat mass in the 
fructose-fed rats was significantly greater than those in the 
non-fructose-fed rats (main treatment effect, P < .05), espe-
cially from 12 to 24 months (P < .05). Bone mass increased 
(Figure 5C), whereas % bone mass decreased with age from 
12 to 24 months of age (main time effect, P < .05). No treat-
ment effect of DOM was found on bone mass, BMD, and 
bone mass.
3.6 | Physical vitality
Horizontal movement distance (Figure  6A) and movement 
speed (Figure 6B) declined progressively from 6 to 24 months 
of age (main time effect, P <  .05). This age-dependent de-
cline was delayed in the D and F groups until 18 months of 
age (P < .05 vs C group). At 24 months of age, both locomo-
tive measurements were similar among groups.
3.7 | Plasma redox status
Trajectories of redox state (GSH/GSSG ratio) of rat survi-
vors at 24 months are shown in Figure 7. The plasma levels 
of GSH (Figure 7A) and GSH/GSSG ratio (Figure 7B) de-
creased progressively with age (main time effect, P < .05), 
until 18 months and resurged at 24 months of age by 61% and 
40% respectively above their 6-month levels (P < .05). Plasma 
GSSG increased by ~50% with age from 6 to 12 months and 
remained stable until 24  months of age. No difference in 
GSH/GSSG ratio was found among groups. When all groups 
were combined and evenly divided into two groups accord-
ing to the change of GSH/GSSG ratio from 18 to 24 months 
of age, rats on the lower halves of GSH/GSSG ratio increase 
showed substantially greater tumor progression (14/47 cases 
with tumor size expansion >100 mm3) compared with their 
higher halve counterparts with only 1 out of 48 cases show-
ing tumor size expansion >100 mm3 (Figure 7C).
4 |  DISCUSSION
This study hypothesized that components in DOM are able 
to compensate for the loss of molecular complexity for ter-
restrial mammals associated with evolutionary sea to land 
T A B L E  2  Location and number of spontaneous tumors among 





C D F FD
Male
Subcutaneous 1   2 2 5
Extraperitoneal 1 1     2
Prostate 1 1 1   3
Lung 6   1 4 11
Liver 2 1   1 4
Kidney     2   2
Gallbladder 1       1
Female
Subcutaneous 8 10 10 12 40
Ventral 2   3 1 6
Extraperitoneal 3     1 4
Intraperitoneal     1   1
Ovary   2 1 1 4
Lung 1   3 3 7
Liver   1     1
Adrenal gland     2   2
Nasal cavity     1   1
Uterus       1 1
Total 26 16 27 26 95
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migration. To evaluate this concept, survival time, tumor 
incidence, and physical vitality were measured. The main 
findings of the study suggest the following: (a) Consuming 
DOM decreases tumorigenesis during mammalian aging. 
This benefit is offset by adding fructose into the drink; (b) 
DOM is neither toxic nor life-prolonging for terrestrial mam-
mals; (c) Daily low concentration fructose drinking does not 
significantly decrease longevity albeit increased fat gain and 
hyperinsulinemia were observed during early age; (d) An 
age-dependent decline in the GSH/GSSG ratio occurs during 
the first 3 quarters of life followed by a resurgence at the end 
period of life regardless of treatments. This resurgence seems 
to be associated with an intrinsic compensatory mechanism 
against tumor formation during the end stages of life but ap-
pears unrelated with any DOM effect on tumor suppression.
The most noteworthy finding of the study is reduced 
tumor incidence in rats consuming DOM under fruc-
tose-free condition versus all other groups. The underly-
ing mechanism to explain this tumor-suppression effect 
could be mediated by direct molecular interaction between 
chemical components of DOM and emerging tumor cells. 
Decreased tumor proliferation and metastasis in human 
breast cancer cell lines4 and HT-29 colorectal cancer cells5 
in media containing DOM have been previously known. 
DOM has enriched divalent ions such as magnesium. In 
humans, higher tumor incidence was observed among mid-
dle-aged individuals (50-76 years) with insufficient mag-
nesium consumption (below RDA) in a 8-year follow-up 
study.6 In contrast, the role of trace elements in DOM on 
tumor incidence remains to be determined.
Another possibility to explain the lower tumor incidence 
with lifelong DOM supplementation is its suppressive effect 
on body mass development, secondary to suppressed energy 
intake. A direct relationship between tumorigenesis and body 
mass gain has been well established.16-18 Therefore, higher 
body mass in fructose-free groups might explain why FD-fed 
rats had not shown a lower tumor suppression. This possibility 
is also supported by our data, showing a substantially greater 
F I G U R E  4  Glucose and insulin. No significant effect of DOM treatment on fasting glucose (A), fasting insulin (B), and glucose AUC (C) in 
blood of the survivors (n = 102) at 24 mo (C, n = 26; D, n = 28; F, n = 25; FD, n = 23) are detected according to two-way ANOVA. Significant 
fructose effect on fasting glucose and glucose AUC was observed at 12 mo of age, but this effect was diminished at 24 mo of age. Abbreviation: C, 
Control; D, Deep ocean mineral water; F, Fructose; FD, Fructose + Deep ocean mineral water, Glucose area under curve (Glucose AUC). *P < .05 
compared against the C group at the same time point; †P < .05 compared against their baseline value at 6 mo
A B C
F I G U R E  5  Body composition. Lean mass slightly increased from 6 to 12 mo of age and decreased thereafter (A). Fat mass increased 
progressively from 6 mo and reaching plateau after 18 mo of age (B). Significant fructose effect on fat mass was observed from 18 to 24 mo of 
age (main effect). These data were collected based on the survivors (n = 102) at 24 mo (C, n = 26; D, n = 28; F, n = 25; FD, n = 23). Bone mass 
showed similar trend as fat mass, but fructose effect was less notable (C). Abbreviation: C, Control; D, Deep ocean mineral water; F, Fructose; FD, 
Fructose + Deep ocean mineral water dual-energy x-ray absorptiometry. *P < .05 compared against the C group at the same time point; †P < .05 
compared against their baseline value at 6 mo
A B C
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tumor incidence associated with quicker body mass gain 
in FD-fed than fructose-free rats (Figure 1). Slower body mass 
gain during growth over time in DOM-treated rats is consis-
tent with previous studies conducted in genetically obese mice 
and high-fat diet (HFD)-induced obese rats.19,20 However, the 
effect of DOM on energy intake and body mass during early 
aging is moderate in our study.
We failed to find significant life-prolonging effects of 
DOM consumption for these naturally aging mammals as re-
ported by previous studies in ovariectomized senescence-ac-
celerated mice (OVX-SAMP8) and streptozotocin-induced 
diabetic rats.10,11 This is probably associated with suppressed 
body mass gain after 19 months of age. Preventing body mass 
gain during the early phase of life is metabolically beneficial 
but loss of body mass at the late stage of life has been linked 
to increase mortality.21,22
During the early period of life, age-dependent body 
mass gain is a major cause of insulin resistance, hyper-
glycemia, tumorigenesis, and premature death for both 
animals and humans.23 Fructose is generally known to 
promote gains in body mass.24 It is thus intriguing that 
greater tumor incidence and hyperinsulinemia in rats 
consuming fructose drinks are not associated with shorter 
longevity. Our data shows that loss of body mass at the 
end of life is also attenuated by fructose. The loss of body 
mass at the end of life is closely associated with increased 
mortality for both rats and humans.21 Furthermore, the 
fructose concentration (11%) of the drink mimicking 
most of the sugar beverages used in humans was consid-
erably lower compared with most of the previous stud-
ies showing negative metabolic survival outcomes.25-27 
Compensatory hyperinsulinemia during body mass gain 
F I G U R E  6  Physical vitality. Horizontal movement distance (A) and movement speed (B) decreased with age. However, the D and F groups 
sustained higher spontaneous locomotive activity until 18 mo of age. The trajectory data were collected based on the survivors (n = 102) at 24 mo 
(C, n = 26; D, n = 28; F, n = 25; FD, n = 23). Abbreviation: C, Control; D, Deep ocean mineral water; F, Fructose; FD, Fructose + Deep ocean 
mineral water. *P < .05 compared against the C group at the same time point; †P < .05 compared within the same group against the baseline at 
6 mo
A B
F I G U R E  7  Plasma glutathione. Reduced glutathione (GSH) (A) and reduced-to-oxidized glutathione ratio (GSH/GSSG) (B) decreased with 
age until 18 mo and resurged at 24 mo of age above 6 mo level. Scatter plot between tumor size progression and magnitude of GSH/GSSG resurged 
from 18 to 24 mo of rats (low GSH/GSSG resurged group vs high GSH/GSSG resurged group) (C). High GSH/GSSG resurged group showed low 
incidence of tumor progression. These data were collected based on the survivors (n = 102) at 24 mo (C, n = 26; D, n = 28; F, n = 25; FD, n = 23). 
Abbreviation: C, Control; D, Deep ocean mineral water; F, Fructose; FD, Fructose + Deep ocean mineral water. *P < .05 compared against the C 
group at the same time point; †P < .05 compared within the same group against the baseline at 6 mo
A B C
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does not appear to be sustainable over time since insulin 
was reversed at the end of life according to the current 
results. A lower decline in insulin28 and body mass29,30 
during the end stage of the life in rats consuming fructose 
may explain why we failed to observe shorter longevity 
in the fructose-fed rats.
The result of the study suggests that the GSH/GSSG 
resurgence is a physiological compensatory mechanism 
against age-associated tumorigenesis. The GSH/GSSG 
ratio declines during aging.31 Very few studies have re-
ported changes in GSH/GSSG until the end period of life. 
In the study, GSH/GSSG trajectories for the first three 
quarters of life (first 18 months) are consistent with exist-
ing knowledge. We observed a resurgence in GSH/GSSG 
at 24 months of age (~average lifespan) among survivors, 
which is consistent among all groups regardless of exper-
imental treatments. Those animals showed substantially 
slower tumor expansion, which was independent of DOM 
consumption, with greater resurgence in GSH/GSSG at 
24 months of age compared with their same age counter-
parts. Dietary GSH supplementation has been shown to 
suppress tumor formation induced by carcinogens in young 
animals32 or tumor progression induced by carcinogens in 
aging animals.33,34 Depleting GSH increases tumorigene-
sis in colons fivefold in p53-knockout mice compared with 
an untreated control group.8,9 However, decreased tumor 
incidence in the DOM group does not appear to be related 
to the GSH/GSSG ratio.
5 |  CONCLUSION
Tumor suppression outcome with lifelong DOM consump-
tion implicates an important role of minerals and trace ele-
ments in the deep ocean on naturally occurring tumorigenesis 
during mammalian aging. DOM are able to compensate loss 
of molecular complexity for terrestrial animals. Our data on 
longevity and physical vitality, suggest that DOM supple-
mentation is safe but not life-prolonging to normally aging 
terrestrial mammals.
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